Presence in

11

states and

13

municipalities

11

facilities:10 Hospitales MAC and one MediMAC in operation

In 2022, we plan to expand our presence with 3 new Hospitales MAC and 8 MediMACs, operating in 14 states and 22 municipalities

2,558

employees


2,051

training courses imparted

18

surgeries for vulnerable populations through Fundación MAC


Creation of the ESG Department at C-level position and hiring of Chief IT Officer

Personal protection equipment, medicines and food donation to first responders and civil organizations in Celaya


Increased presence with our acquisitions and new developments: Periférico Sur (full year), Aguascalientes Norte, Tampico and MediMAC Tlalnepantla

100 %

patients helped and treated during the COVID-19 pandemic, whether at home via our “MAC en casa” program or in our hospitals, we provided medical attention to all patients who came to us

Rated as AA- by Verum and HR Ratings, an improvement from A+ in April 2021, which allowed us to issue a second public debt of 1,500 million pesos in July 2021

Continuous investment for equipment renewal in all our hospitals in the face of the pandemic, from ventilators and patient monitors to CT scanners and MRIs

Periférico Sur Hospital was acquired towards the end of 2020, since then we opened a CardioMAC and our certified ECMO center within was the most productive in the entire country

Placed as

26 th

in the Super Places to Work ranking of Expansión Magazine

Celaya Hospital achieved the

49 th

place in the Best Private Hospitals ranking of Expansión Magazine

Hans Omar Sánchez Velarde and Alejandra Mireles Guerrero were appointed as Chief IT Officer and Chief Human Capital Officer, respectively

Incorporation of María Mercedes Ariza García and Cosme Alberto Torrado Martínez to our Board of Directors

Members of HealthTech Mexico, an association to promote the use of technology for health purposes

$3,143 million

pesos in revenues; +74.4% vs 2020

$536.8 million

pesos in operating profit; +87.5% vs 2020

$796.8 million

pesos in EBITDA; +120% vs 2020